设计成模仿互白素-21的强有力的抗瘤活性
bioRxiv : the preprint server for biology
|December 16, 2024
概括
一种新的IL-21模仿剂,21h10,有效地激活多种细胞毒性T细胞,并抑制调节性T细胞以获得强大的抗瘤免疫力. 这种免疫疗法方法显示出治疗各种癌症的巨大潜力.
科学领域:
- 免疫学 免疫学 免疫学
- 在瘤学瘤学.
- 生物技术是生物技术.
背景情况:
- 癌症免疫疗法旨在增强细胞毒性T细胞反应,同时降低调控性T细胞活性,但目前的方法有局限性.
- 介乐-21 (IL-21) 是一种参与免疫调节和T细胞功能的细胞因子,但其治疗应用受到稳定性和功效问题的限制.
研究的目的:
- 开发和评估一种新的,稳定的,强大的IL-21模仿剂 (21h10) 用于癌症免疫治疗.
- 在临床前模型和人类瘤样本中评估21h10的抗瘤疗效和免疫调节作用.
主要方法:
- 设计和合成一个新的IL-21模拟器 (21h10),增强稳定性和信号强度.
- 在多种动物癌症模型和ex vivo人类黑色素瘤患者衍生器官型瘤球体 (PDOTS) 中评估21h10的抗瘤活性.
- 分析STAT信号,T细胞反应 (细胞毒性和调节性) 和21点10分给药后瘤微环境中的细胞因子产生.
主要成果:
- 21h10在各种模型中表现出强大的抗瘤活性,显著超过原生IL-21.
- 模仿器在体内诱导了长时间的STAT信号传递,并扩大了低亲和力细胞毒性T细胞,增强了干扰素- (IFN-γ) 和大酶B的表达.
- 21h10增加了瘤微环境中的IFN-γ+ Th1细胞和减少了Foxp3+调节性T细胞 (Tregs).
- 与21h10相关的全身毒性可以通过TNFα阻断得到控制,而不会影响疗效.
结论:
- 模仿21h10的IL-21代表了癌症免疫治疗的有前途的治疗剂,因为它强烈地激活了各种抗瘤T细胞,并抑制了Tregs.
- 21h10的交叉反应性,稳定性,功效和强化低亲和性T细胞反应的能力为临床应用提供了显著的翻译潜力.
相关概念视频
01:27Tumor Immunotherapy
475
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
475
02:57Targeted Cancer Therapies
7.4K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.4K